These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 22392489)
1. c-Kit proto-oncogene expression in endometrial hyperplasia and endometrial cancer. Yilmaz E; Celik O; Simsek Y; Turkcuoglu I; Celik E; Gül M; Hascalik S; Aydin NE Arch Gynecol Obstet; 2012 Jul; 286(1):197-200. PubMed ID: 22392489 [TBL] [Abstract][Full Text] [Related]
2. Relationships between C-kit expression and mean platelet volume in benign, preneoplastic and neoplastic endometrium. Sehitoglu I; Bedir R; Ural UM; Gucer H; Yurdakul C; Cure MC; Cure E; Yuce S; Sahin FK Asian Pac J Cancer Prev; 2015; 16(4):1495-9. PubMed ID: 25743820 [TBL] [Abstract][Full Text] [Related]
3. Expression pattern of PAX2 in hyperplastic and malignant endometrium. Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645 [TBL] [Abstract][Full Text] [Related]
4. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Afify AM; Craig S; Paulino AF; Stern R Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis and apoptosis-related factors Bcl-2, Bax, tumor necrosis factor-alpha, and NF-kappaB in human endometrial hyperplasia and carcinoma. Vaskivuo TE; Stenbäck F; Tapanainen JS Cancer; 2002 Oct; 95(7):1463-71. PubMed ID: 12237915 [TBL] [Abstract][Full Text] [Related]
6. Galectin-3 expression in normal, hyperplastic, and neoplastic endometrial tissues. Brustmann H; Riss D; Naudé S Pathol Res Pract; 2003; 199(3):151-8. PubMed ID: 12812316 [TBL] [Abstract][Full Text] [Related]
7. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma. Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
9. Expression of c-kit (CD117) in benign and malignant human endometrial epithelium. Elmore LW; Domson K; Moore JR; Kornstein M; Burks RT Arch Pathol Lab Med; 2001 Jan; 125(1):146-51. PubMed ID: 11151069 [TBL] [Abstract][Full Text] [Related]
10. Cyclical change of hMSH2 protein expression in normal endometrium during the menstrual cycle and its overexpression in endometrial hyperplasia and sporadic endometrial carcinoma. Hamid AA; Mandai M; Konishi I; Nanbu K; Tsuruta Y; Kusakari T; Kariya M; Kita M; Fujii S Cancer; 2002 Feb; 94(4):997-1005. PubMed ID: 11920468 [TBL] [Abstract][Full Text] [Related]
11. Gain of OGP, an estrogen-regulated oviduct-specific glycoprotein, is associated with the development of endometrial hyperplasia and endometrial cancer. Woo MM; Alkushi A; Verhage HG; Magliocco AM; Leung PC; Gilks CB; Auersperg N Clin Cancer Res; 2004 Dec; 10(23):7958-64. PubMed ID: 15585630 [TBL] [Abstract][Full Text] [Related]
12. Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Mylonas I; Makovitzky J; Richter DU; Jeschke U; Briese V; Friese K Gynecol Oncol; 2004 Apr; 93(1):92-7. PubMed ID: 15047219 [TBL] [Abstract][Full Text] [Related]
13. Adrenomedullin, Bcl-2 and microvessel density in normal, hyperplastic and neoplastic endometrium. Nunobiki O; Nakamura M; Taniguchi E; Utsunomiya H; Mori I; Tsubota Y; Mabuchi Y; Kakudo K Pathol Int; 2009 Aug; 59(8):530-6. PubMed ID: 19627536 [TBL] [Abstract][Full Text] [Related]
14. Progressive derailment of cell cycle regulators in endometrial carcinogenesis. Horrée N; van Diest PJ; van der Groep P; Sie-Go DM; Heintz AP J Clin Pathol; 2008 Jan; 61(1):36-42. PubMed ID: 17483252 [TBL] [Abstract][Full Text] [Related]
15. KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer. Liu FS; Dong JT; Chen JT; Hsieh YT; Ho ES; Hung MJ; Lu CH; Chiou LC Clin Cancer Res; 2003 Apr; 9(4):1393-8. PubMed ID: 12684410 [TBL] [Abstract][Full Text] [Related]
16. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables. Ozuysal S; Oztürk H; Bilgin T; Filiz G Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230 [TBL] [Abstract][Full Text] [Related]
17. Estrogen and progesterone receptors and cyclooxygenase-2 expression in endometrial cancer, endometrial hyperplasia, and normal endometrium. Orejuela FJ; Ramondetta LM; Smith J; Brown J; Lemos LB; Li Y; Hollier LM Gynecol Oncol; 2005 May; 97(2):483-8. PubMed ID: 15863148 [TBL] [Abstract][Full Text] [Related]
18. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas. Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the insulin-like growth factor I receptor and activation of the AKT pathway in hyperplastic endometrium. McCampbell AS; Broaddus RR; Loose DS; Davies PJ Clin Cancer Res; 2006 Nov; 12(21):6373-8. PubMed ID: 17085648 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis, bcl-2 expression, and proliferation in benign and malignant endometrial epithelium: An approach using multiparameter flow cytometry. Morsi HM; Leers MP; Radespiel-Tröger M; Björklund V; Kabarity HE; Nap M; Jäger W Gynecol Oncol; 2000 Apr; 77(1):11-7. PubMed ID: 10739685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]